Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.

• 主要な著者: Shyam Sundar (著者), Krishna Pandey (著者), Chandreshwar Prasad Thakur (著者), Tara Kant Jha (著者), Vidya Nand Ravi Das (著者), Neena Verma (著者), Chandra Shekhar Lal (著者), Deepak Verma (著者), Shahnawaz Alam (著者), Pradeep Das (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2014-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The authors evalu...